The impact of E-cadherin expression on non-small cell lung cancer survival: a meta-analysis

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecular Biology Reports

• Publication date

  2012-06-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11033-012-1827-1PMID 22729914
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Statistics, 2011: The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths

  2012cited by this paper
• Valor pronóstico del receptor del factor de crecimiento epitelial, factor de crecimiento endotelial vascular, E-cadherina, y p120 catenina en el carcinoma de pulmón no microcítico resecado

  2011cited by this paper
• Cancer statistics, 2011

  2011cited by this paper
• [Prognostic value of epithelial growth factor receptor, vascular endothelial growth factor, E-cadherin, and p120 catenin in resected non-small cell lung carcinoma].

  2011cited by this paper
• The E-cadherin (CDH1) −160C>A Polymorphism Associated with Gastric Cancer Among Asians But Not Europeans

  2011cited by this paper
• The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

  2010cited by this paper
• Deregulation of p27 and Cyclin D1/D3 Control Over Mitosis Is Associated with Unfavorable Prognosis in Non-small Cell Lung Cancer, as Determined in 405 Operated Patients

  2010cited by this paper
• Epithelial-mesenchymal transition in EGFR-TKI acquired resistant lung adenocarcinoma.

  2010cited by this paper
• Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites.

  2010cited by this paper
• Prognostic impact of vascular endothelial growth factor-A and E-cadherin expression in completely resected pathologic stage I non-small cell lung cancer.

  2010cited by this paper
• Soluble adhesion molecules E-cadherin, intercellular adhesion molecule-1, and E-selectin as lung cancer biomarkers.

  2010cited by this paper
• Expression of dysadherin and cytokeratin as prognostic indicators of disease-free survival in patients with stage I NSCLC.

  2010cited by this paper
• Expression of integrin-linked kinase in lung squamous cell carcinoma and adenocarcinoma: correlation with E-cadherin expression, tumor microvessel density and clinical outcome

  2010cited by this paper
• Association between lymphangiogenesis-/micrometastasis- and adhesion-related molecules in resected stage I NSCLC.

  2010cited by this paper
• Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients

  2008cited by this paper
• The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer

  2008cited by this paper
• Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression.

  2007cited by this paper
• E-cadherin Immunohistochemical Expression as a Prognostic Factor in Infiltrating Ductal Carcinoma of the Breast: a Systematic Review and Meta-Analysis

  2006cited by this paper
• The clinical significance of soluble E-cadherin in nonsmall cell lung cancer.

  2006cited by this paper
• New signals from the invasive front

  2006cited by this paper
• SEER Cancer Statistics Review, 1975-2003

  2006cited by this paper
• Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.

  2006cited by this paper
• Temporal trends in small cell lung cancer: Analysis of the national Surveillance, Epidemiology, and End-Results (SEER) database.

  2006cited by this paper
• Differences of E-cadherin expression levels and patterns in primary and metastatic human lung cancer

  2005cited by this paper
• Clinical application of biological markers for treatments of resectable non-small-cell lung cancers

  2005cited by this paper
• Prognostic significance of dysadherin expression in patients with non-small cell lung cancer.

  2005cited by this paper
• No one-way street: Cross-talk between E-cadherin and receptor tyrosine kinase (RTK) signaling—A mechanism to regulate RTK activity

  2005cited by this paper
• Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.

  2004cited by this paper
• Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry

  2004cited by this paper
• Classical cadherin adhesion molecules: coordinating cell adhesion, signaling and the cytoskeleton

  2004cited by this paper
• E‐cadherin‐mediated adhesion inhibits ligand‐dependent activation of diverse receptor tyrosine kinases

  2004cited by this paper
• Cell adhesion and signalling by cadherins and Ig-CAMs in cancer

  2004cited by this paper
• E-Cadherin Binding Modulates EGF Receptor Activation

  2003cited by this paper
• E-cadherin expression in primary carcinomas of the breast and its distant metastases

  2003cited by this paper
• Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer.

  2003cited by this paper
• Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients

  2003cited by this paper
• Regulation of E-cadherin/catenin complex patterns by epidermal growth factor receptor modulation in human lung cancer cells.

  2002cited by this paper
• The significance of E-cadherin and alpha-, beta-, and gamma-catenin expression in surgically treated non-small cell lung cancers of 3 cm or less in size.

  2002cited by this paper
• The significance of E-cadherin and α-, β-, and γ-catenin expression in surgically treated non–small cell lung cancers of 3 cm or less in size

  2002cited by this paper
• High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer.

  2002cited by this paper
• E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer.

  2001cited by this paper
• Expression of E-cadherin and lymph node metastasis in resected non-small-cell lung cancer.

  2001cited by this paper
• Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis.

  2001cited by this paper
• Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance.

  2000cited by this paper
• Expression of E-cadherin and β-catenin in human non-small cell lung cancer and the clinical significance

  2000cited by this paper
• Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis.

  2000cited by this paper
• Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer

  1999cited by this paper
• Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer.

  1998cited by this paper
• Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints.

  1998cited by this paper
• Expression of E-cadherin in primary and metastatic prostate cancer.

  1996cited by this paper
• Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer.

  1996cited by this paper
• E‐cadherin mediated adhesion system in cancer cells

  1996cited by this paper
• Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.

  1995cited by this paper
• Adhesion molecules: novel molecular tools in tumor pathology.

  1994cited by this paper
• Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene

  1993cited by this paper
• Expression of immunoreactive E-cadherin adhesion molecules in human cancers.

  1991cited by this paper
• Cadherins: a molecular family important in selective cell-cell adhesion.

  1990cited by this paper
• Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion

  1989cited by this paper
• Publication bias : a problem in interpreting medical data

  1988cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Beta blockade during and after myocardial infarction: an overview of the randomized trials.

  1985cited by this paper
• E‐cadherin mediated adhesion system in cancer cells

  year unknowncited by this paper

• Expression of Ki-67 and E-cadherin in patients with non-small cell lung cancer attending a tertiary care hospital

  2023cites this paper
• LncCDH5-3:3 Regulates Apoptosis, Proliferation, and Aggressiveness in Human Lung Cancer Cells

  2022cites this paper
• Meta-analysis of downregulated E-cadherin as a diagnostic biomarker for cervical cancer

  2022cites this paper
• Clinicopathological significance and prognostic value of E-cadherin expression in non-small cell lung cancer

  2021cites this paper
• SATB1 protein is associated with the epithelial-mesenchymal transition process in non-small cell lung cancers

  2021cites this paper
• Artesunate inhibits epithelial-mesenchymal transition in non-small-cell lung cancer (NSCLC) cells by down-regulating the expression of BTBD7

  2020cites this paper
• Rectum cancers with distant metastases (Stage IV) show decreased tissue expression of E cadherin at the invasive tumor front

  2020cites this paper
• Overexpression of Raf-1 kinase inhibitor protein inhibits cell invasion and migration in lung cancer cells through suppressing epithelial-mesenchymal transition

  2019cites this paper
• Impact of EMT in stage IIIB/IV NSCLC treated with erlotinib and bevacizumab when compared with cisplatin, gemcitabine and bevacizumab

  2019cites this paper
• E‐Cadherin Loss Accelerates Tumor Progression and Metastasis in a Mouse Model of Lung Adenocarcinoma

  2018cites this paper
• E-cadherin: Its dysregulation in carcinogenesis and clinical implications.

  2018cites this paper
• Non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in non-small cell lung cancer

  2017cites this paper
• Prognostic significance of β-catenin expression in patients with non-small cell lung cancer: a meta-analysis.

  2017cites this paper
• Mechanism of BRG1 silencing in primary cancers

  2016cites this paper
• The prognostic implication of slug in all tumour patients – a systematic meta‐analysis

  2016cites this paper
• SWI/SNF Chromatin Remodelling and Human Cancer

  2016cites this paper
• High expression of E-cadherin in pleural effusion cells predicts better prognosis in lung adenocarcinoma patients.

  2015cites this paper
• Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification

  2015cites this paper
• PD-L1 over-expression and survival in patients with non-small cell lung cancer: a meta-analysis.

  2015cites this paper
• Original Article Prognostic significance of reduced immunohistochemical expression of E-cadherin in endometrial cancer-results of a meta-analysis

  2015cites this paper
• Prognostic value of TTF-1 expression in patients with non-small cell lung cancer: A meta-analysis.

  2015cites this paper
• The role of SOX-2 on the survival of patients with non-small cell lung cancer.

  2015cites this paper
• Prognostic significance of reduced immunohistochemical expression of E-cadherin in endometrial cancer-results of a meta-analysis.

  2015cites this paper
• Meta-analysis: E-cadherin immunoexpression as a potential prognosis biomarker related to gastric cancer metastasis in Asian patients.

  2014cites this paper
• Emerging Lung Cancer Therapeutic Targets Based on the Pathogenesis of Bone Metastases

  2014cites this paper
• Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer.

  2014cites this paper
• Identificación mediante inmunohistoquímica de factores pronósticos biomoleculares en el carcinoma broncogénico no microcítico en estadio precoz resecado

  2014cites this paper
• Prognostic role of Twist or Snail in various carcinomas: a systematic review and meta‐analysis

  2014cites this paper
• Prognostic and Clinicopathological Significance of Downregulated E-Cadherin Expression in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis

  2014cites this paper
• 非小细胞肺癌中EMT的发生机制及预后价值的研究进展

  2014cites this paper
• The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis.

  2013cites this paper
• Prognostic value of TTF-1 expression in patients with non-small cell lung cancer: a meta-analysis

  2013cites this paper
• VEGF +936C/T and +460C/T gene polymorphisms and oral cancer risk: a meta-analysis

  2013cites this paper
• Key molecular mechanisms in lung cancer invasion and metastasis: a comprehensive review.

  2013cites this paper
• Prognostic value of COX-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.

  2013cites this paper
• Downregulated E-Cadherin Expression Indicates Worse Prognosis in Asian Patients with Colorectal Cancer: Evidence from Meta-Analysis

  2013cites this paper
• Prognostic significance of β-catenin expression in patients with non-small cell lung cancer: a meta-analysis.

  2013cites this paper